Catalyst Wire Dossier Catalyst Wire Dossier

ABX-101

· Abalonex, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABX-101, covering 2023-10-23 to 2023-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury [Phase 2]

See pricing